Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
International Journal of Molecular Sciences
|
November 9, 2017
Vitamin D and VDR in Gynecological Cancers-A Systematic Review
Eileen Deuster, Udo Jeschke, Yao Ye, et al.
STAR Protocols
|
August 16, 2023
Protocol to optimize the biobanking of ovarian cancer organoids by accommodating patient-specific differences in stemness potential
Fabian Trillsch, Bastian Czogalla, Fabian Kraus, et al.
Cancers
|
May 14, 2022
Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer
Oliver Ingo Hoffmann, Manuel Regenauer, Bastian Czogalla, et al.
Journal of Visualized Experiments : Jove
|
March 11, 2024
Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Fabian Trillsch, Juliane Reichenbach, Bastian Czogalla, et al.
Biomedicines
|
April 23, 2022
A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape
Markus Kellner, Bettina von Neubeck, Bastian Czogalla, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 27, 2023
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy
Anca Chelariu-Raicu, Fabian Trillsch, Alexander Burges, et al.
Plos One
|
July 28, 2022
Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas
Lisa Hiepp, Doris Mayr, Kathrin Gärtner, et al.
Journal of Reproductive Immunology
|
January 15, 2019
Involvement of ILR4α and TLR4 in miscarriages
Theresa Maria Kolben, Elisabeth Rogatsch, Anna Hester, et al.
Archives of Gynecology and Obstetrics
|
April 7, 2018
Peri-operative oral immunonutrition in malnourished ovarian cancer patients assessed by the nutritional risk screening
Linda Hertlein, Christine Zeder-Göß, Sophie Fürst, et al.
Oncotargets and Therapy
|
September 20, 2019
EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells
Anna Hester, Barbara Salzmann, Martina Rahmeh, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
International Journal of Molecular Sciences
|
November 9, 2017
Vitamin D and VDR in Gynecological Cancers-A Systematic Review
Eileen Deuster, Udo Jeschke, Yao Ye, et al.
STAR Protocols
|
August 16, 2023
Protocol to optimize the biobanking of ovarian cancer organoids by accommodating patient-specific differences in stemness potential
Fabian Trillsch, Bastian Czogalla, Fabian Kraus, et al.
Cancers
|
May 14, 2022
Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer
Oliver Ingo Hoffmann, Manuel Regenauer, Bastian Czogalla, et al.
Journal of Visualized Experiments : Jove
|
March 11, 2024
Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Fabian Trillsch, Juliane Reichenbach, Bastian Czogalla, et al.
Biomedicines
|
April 23, 2022
A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape
Markus Kellner, Bettina von Neubeck, Bastian Czogalla, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 27, 2023
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy
Anca Chelariu-Raicu, Fabian Trillsch, Alexander Burges, et al.
Plos One
|
July 28, 2022
Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas
Lisa Hiepp, Doris Mayr, Kathrin Gärtner, et al.
Journal of Reproductive Immunology
|
January 15, 2019
Involvement of ILR4α and TLR4 in miscarriages
Theresa Maria Kolben, Elisabeth Rogatsch, Anna Hester, et al.
Archives of Gynecology and Obstetrics
|
April 7, 2018
Peri-operative oral immunonutrition in malnourished ovarian cancer patients assessed by the nutritional risk screening
Linda Hertlein, Christine Zeder-Göß, Sophie Fürst, et al.
Oncotargets and Therapy
|
September 20, 2019
EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells
Anna Hester, Barbara Salzmann, Martina Rahmeh, et al.
Page
of 7